top of page
amys-foundation-logo (3).png
amy.jpg

MEET AMY

On July 13, 1964, the world welcomed Amy Louise Daniels, a remarkable person who was born with the BRCA-1 gene, which causes carriers to have a significant risk of developing ovarian and breast cancer. From the beginning, she faced a daunting destiny linked to this gene.

During the time that I knew her, Amy often questioned why she had to bear such a burden. My response was always the same: to help save lives. I would tell her what I believe to be true: “GOD chose you because he knew you would be the right person to handle this knowledge and to use it to help others around you.”

about-amy-img-4.jpg
about-amy-img-3.jpg
about-amy-img-1.jpg

There is Not an Early Detection Test for Ovarian Cancer—yet

It took over 100 years to develop tests like the pap smear and mammogram. That's why ongoing support is vital.

Research takes time

Developing tests like the pap smear took over a century. It’s a long journey.

Monthly support

Whether it’s $1 or $1,000 a month, every dollar pushes research forward. Monthly donations will save lives.

DONORS OVER DOLLARS

We’re building a community of committed supporters. It’s about consistency, not size.

FUND EARLY DETECTION

Your support will help fund the first early detection test for ovarian cancer.

priscilla-du-preez-cIfLUEZYLVg-unsplash.jpg
cleveland-clinic-logo-png.avif

Together, We Can Develop the First Early Detection Test for Ovarian Cancer

In memory of Amy, we are partnering with Cleveland Clinic to change the fact that no early detection test exists.

Fueling Early Detection Research with Cleveland Clinic

Taussig Center Logo.png
amys-foundation-logo (3).png

We’re working with one of the world’s top research hospitals to develop an early detection test for ovarian cancer—because no woman should die from a cancer we could have caught sooner.

AMY 1 copy.png

This test SHOULD already exist

Yet there’s still no early detection test for ovarian cancer.

Early Detection Available?

Breast Cancer

Mammogram

Cervical Cancer

Pap Smear

Ovarian Cancer

None. No early detection.
 
70% are diagnosed after it’s already stage III or IV.

Avg. 5-Year Survival Rate

90%

92%

30%

Together, we’re changing the story for women.
Stay connected.

By clicking 'Subscribe' I accept the terms and conditions of the privacy policy and consent to receive email updates and stories from Amy's Foundation

bottom of page